My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Neogen Corporation - Common Stock (NQ:NEOG)

10.38 +0.37 (+3.65%)

Streaming Delayed Price Updated: 2:49 PM EST, Jan 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Neogen Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

3 Russell 2000 Stocks We Keep Off Our Radar

January 18, 2026

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...

Via StockStory

Neogen (NEOG) Q2 2026 Earnings Call Transcript ↗

January 15, 2026

Neogen (NEOG) Q2 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings World Trade

5 Insightful Analyst Questions From Neogen’s Q4 Earnings Call

January 15, 2026

Neogen’s Q4 results were met with a strong positive market reaction, reflecting the company’s return to positive core growth and substantial margin improvement. Management attributed the quarter’s...

Via StockStory

Topics Earnings

3 Inflated Stocks with Warning Signs

January 14, 2026

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro...

Via StockStory

NEOG Q4 Deep Dive: Operational Improvements and New Leadership Drive Upbeat Outlook

January 09, 2026

Life sciences company Neogen (NASDAQ:NEOG) reported Q4 CY2025 results topping the market’s revenue expectations, but sales fell by 2.8% year on year to $224.7 million. The company’s full-year revenue...

Via StockStory

Why Neogen Stock Blasted More Than 31% Higher Today ↗

January 08, 2026

The company delivered an estimates-trouncing quarter for its shareholders.

Via The Motley Fool

Why Is Neogen (NEOG) Stock Rocketing Higher Today

January 08, 2026

Shares of life sciences company Neogen (NASDAQ:NEOG) jumped 27.6% in the morning session after the company reported fourth-quarter results that far surpassed Wall Street's expectations and raised its...

Via StockStory

Topics Artificial Intelligence World Trade

These stocks are gapping in today's session ↗

January 08, 2026

Via Chartmill

Neogen Shares Skyrocket as Q2 Earnings Beat Signals Turning Point in 3M Integration Strategy

January 08, 2026

LANSING, MI – Shares of Neogen Corporation (NASDAQ: NEOG) experienced a dramatic surge in early trading today, climbing nearly 29% after the food and animal safety leader reported second-quarter fiscal...

Via MarketMinute

Topics Earnings Economy

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

January 08, 2026

Via Chartmill

Neogen (NASDAQ:NEOG) Beats Expectations in Strong Q4 CY2025, Stock Jumps 19.8%

January 08, 2026

Life sciences company Neogen (NASDAQ:NEOG) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 2.8% year on year to $224.7 million. The company’s full-year revenue...

Via StockStory

Neogen (NEOG) Q4 Earnings Report Preview: What To Look For

January 06, 2026

Life sciences company Neogen (NASDAQ:NEOG) will be reporting results this Thursday before the bell. Here’s what to expect.

Via StockStory

1 Healthcare Stock on Our Watchlist and 2 We Ignore

January 04, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also...

Via StockStory

Topics Stocks

3 Unpopular Stocks with Warning Signs

December 21, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

3 Reasons to Sell NEOG and 1 Stock to Buy Instead

December 18, 2025

Neogen has been on fire lately. In the past six months alone, the company’s stock price has rocketed 52.1%, reaching $7.52 per share. This was partly due to its solid quarterly results, and the...

Via StockStory

Topics Bankruptcy

3 Stocks Under $10 We Steer Clear Of

December 08, 2025

Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be...

Via StockStory

3 Unprofitable Stocks with Questionable Fundamentals

December 03, 2025

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Via StockStory

1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds

December 01, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

Myriad Genetics, Neogen, ICU Medical, HCA Healthcare, and Universal Health Services Stocks Trade Up, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government...

Via StockStory

Topics Economy Government

CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Artificial Intelligence Economy Stocks

Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

3 of Wall Street’s Favorite Stocks Walking a Fine Line

November 06, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

Neogen (NASDAQ:NEOG) Q3 Earnings: Leading The Medical Devices & Supplies - Diversified Pack

November 04, 2025

Let’s dig into the relative performance of Neogen (NASDAQ:NEOG) and its peers as we unravel the now-completed Q3 medical devices & supplies - diversified earnings season.

Via StockStory

3 Russell 2000 Stocks We Find Risky

October 17, 2025

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the...

Via StockStory

5 Revealing Analyst Questions From Neogen’s Q3 Earnings Call

October 16, 2025

Neogen’s third quarter results were met with a strong positive market reaction, despite reporting a year-over-year sales decline. Management attributed the quarter’s performance to ongoing operational...

Via StockStory

Topics Earnings

2 Unprofitable Stocks for Long-Term Investors and 1 We Question

October 15, 2025

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Via StockStory

Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

NEOG Q3 Deep Dive: Q3 Results, Guidance Reaffirmed, and Operational Turnaround in Focus

October 10, 2025

Life sciences company Neogen (NASDAQ:NEOG) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 3.6% year on year to $209.2 million. The company’s full-year revenue...

Via StockStory

Animal Tester Neogen Sticks To Annual Forecast Despite Tariffs ↗

October 09, 2025

Neogen stock rises after Q1 sales beat expectations, driven by food and animal safety growth, while the company maintains full-year 2026 guidance.

Via Benzinga

Topics Earnings

Why Neogen (NEOG) Stock Is Trading Up Today

October 09, 2025

Shares of life sciences company Neogen (NASDAQ:NEOG) jumped 21.4% in the morning session after the company reported third-quarter 2025 financial results that surpassed revenue expectations while its...

Via StockStory

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.